Efficacy and Duration of Biological Therapies among Saudi Patients with Psoriasis
Background: The long-term efficacy of biological agents in a Saudi population differs from other populations. Purpose: We studied 12 patients with moderate-to-severe psoriasis undergoing biological treatment to assess the long-term efficacy of these medications in the Saudi Arabian population. Metho...
Saved in:
Main Authors: | Sami N. Alsuwaidan, Abdullah M. AlMuqrin, Tala A. Qadoumi, Batal M. Aldosari, Abdulmajeed M. AlAjlan |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Journal of Dermatology and Dermatologic Surgery |
Subjects: | |
Online Access: | https://journals.lww.com/10.4103/jdds.jdds_51_24 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adalimumab‐Induced Cutaneous Lupus Erythematosus: Cases Presenting With Malar Rash and Panniculitis
by: Parvin Mansouri, et al.
Published: (2025-01-01) -
Breakthrough Psoriasis in Patients Receiving Biologicals
by: Damsin T, et al.
Published: (2025-01-01) -
Reduction of depressive symptoms among patients with inflammatory bowel disease treated with biological therapy: a quantitative comparative incision study
by: J. Zinkevičiūtė, et al.
Published: (2019-06-01) -
Portuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy – a delphi methodology
by: Tiago Torres, et al.
Published: (2025-12-01) -
Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study
by: Mishari Alrubaiaan, et al.
Published: (2025-01-01)